Certified by Founder Lodge
Rampart Bioscience
United States - Delhi, California
START UP
1 Disclosed Funding Rounds $85,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Rampart Bioscience is evolving a new class of medicines for patients with genetically driven diseases. We integrate capabilities from a variety of key scientific disciplines — including gene
OrbiMed
HealthCap
Forbion
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Zócalo Health | $15,000,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
Brev.io | $3,300,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
